MedPath

Midkine Role With Deregulated Oxidative and Immune Milieu in Induction of Preeclampsia

Not Applicable
Completed
Conditions
Pre-Eclampsia
Interventions
Diagnostic Test: ELISA
Registration Number
NCT06329284
Lead Sponsor
Benha University
Brief Summary

Preeclampsia (PE) is a hypertensive pregnancy-related disorder that endangers maternal and fetal outcomes and accounts for 9-10% of maternal mortalities with its early-onset phenotype is the most dangerous, but its etiology is still not fully elucidated.

Midkine (MDK) is a multifunctional protein that plays a unique role in the development of hypertension (HTN), via its proatherogenic effect and induction of overexpression of angiotensin converting enzyme. Oxidative stress (OS) upregulates the expression of MDK and MDK induces propagation of neoangiogenesis and acts as chemotactic for neutrophils.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Newly pregnant normotensive (NT) women with singleton fetus;
  • Free of the Exclusion Criteria.
Exclusion Criteria
  • Women with history of complicated pregnancy;
  • Had manifest essential hypertension, Diabetes Mellitus or chronic kidney diseases;
  • Had multiple gestational sacs, morbid obesity with Body Mass Index at time of pregnancy diagnosis over 35 kg/m2;
  • Had genetic disorders, coagulopathy, autoimmune diseases or maintained on immunosuppressive therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Serum MidkineELISA-
Primary Outcome Measures
NameTimeMethod
Severity of Pre-Eclampsia (PE)8 months

Correlation between Serum midkine levels and blood pressure measurements

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Banha University

🇪🇬

Banhā, El- Qalyobia, Egypt

© Copyright 2025. All Rights Reserved by MedPath